The Evolving Role of Neoadjuvant Therapy in Breast Cancer |
04/20/2020 - 12:00pm to 1:00pm |
Access to new cancer drugs and managing drug costs in a fiscally constrained health care system: can both be achieved? |
03/02/2020 - 12:00pm to 1:00pm |
Cellular Dynamics of Multiple Myeloma |
01/27/2020 - 12:00pm to 1:00pm |
Co-Clinical Trials Targeting DNA Repair and Oncogenic Signaling Pathways to Enhance Responsiveness to Cancer Immunotherapy |
08/26/2019 - 12:00pm to 1:00pm |
Connecting the Dots of Behavioral Economics and Medical Decision-Making: Exploring Ambiguity Aversion’s Relationship to Biosimilar Prescribing |
10/07/2019 - 12:00pm to 1:00pm |
Cure Without Morbidity: Minimizing Pyrrhic Victories in Hematologic Malignancies |
01/06/2020 - 12:00pm to 1:00pm |
Current Treatment Options for Metastatic Urothelial Cancer and Focus on Enfortumab Vedotin” & “Medical Futility: Navigating Difficult Conversations Near the End of Life” |
06/29/2020 - 12:00pm to 1:00pm |
Drugging the Undruggable: Anti-Ras Therapy |
12/23/2019 - 12:00pm to 1:00pm |
Endocrine Disorders and Cancer Therapy |
05/11/2020 - 12:00pm to 1:00pm |
Evaluating Care, Quality of Life, and Mental Health Outcomes in Adults with Sickle Cell Disease |
12/02/2019 - 12:00pm to 1:00pm |